Cinnarizine, an HRH1 (histamine receptor H1), DRD2 (dopamine receptor D2) and calcium channel antagonist commonly used to treat motion sickness, may be re-purposed to treat symptoms of schizophrenia (see Fig. 5)62. The gene discussed is HRH1; the disease is schizophrenia.